QSA's Week in BioPharma (#8, 2024)
McMaster's new chemistry center; Pharmacare Act for diabetes; BIOTECanada's biotechnology mission; Stem cell research in diabetes; Investment in life sciences.
BioPharma
Queen Street Analytics' weekly digest of regulatory developments, legislative discussions, political announcements and other government-related news in biotech, pharmaceutical manufacturing, drug distribution and pricing, the life sciences and medical research.
QSA's Week in BioPharma (#7, 2024)
Pharmacare plan expands; Minister Holland at healthcare summit; AMR awareness rises.
QSA's Week in BioPharma (#6, 2024)
Pharmacare committee formed; Avian flu research funded; NL drug access expanded; Medical device regulation updated.
QSA's Week in BioPharma (#5, 2024)
PMPRB report on drug spending; Senate examines Food and Drugs Act bill; Pharmacare Act and diabetes focus.
QSA's Week in BioPharma (#4, 2024)
Bill C-368 debates impact NHP industry; Capstone org proposed for research; FNHA joins CAN Health Network; Reproductive health legislation planned; CAN Dental Care covers 2.7M Canadians.
QSA's Week in BioPharma (#3, 2024)
Capstone Research Funding plans outlined; NAPAHPI initiative announced; $13.7M for women's health research; Pharmacare Act insights.
QSA's Week in BioPharma (#2, 2024)
New Pharmacare Act receives Royal Assent; PMPRB gains new appointee; Research support system engagement report released; EVAH Corp receives substantial CED funding.